MedTrace Logo

CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation

NCT00889265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2014-08-11

Study results available
· View outcomes & findings →

Summary

This is a prospective, multi-center study to evaluate the use of CopiOs Pericardium Membrane, a bovine xenograft, with use of Puros Cancellous Particulate Allograft, for the augmentation of localized alveolar ridge defects on either the maxilla or mandible.

Conditions

  • Alveolar Ridge Defect

Interventions

DEVICE

CopiOs Pericardium Membrane

CopiOs Pericardium, Puros Cancellous

Sponsors & Collaborators

  • Zimmer Dental

    collaborator INDUSTRY

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Brian Mealy · University of Texas Health Sciences Center at San Antonio

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889265 on ClinicalTrials.gov